<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2014-7-eng-47-50</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-624</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ИССЛЕДОВАТЕЛЬСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND INVESTIGATIVE MEDICINE</subject></subj-group></article-categories><title-group><article-title>РАСПРОСТРАНЕННОСТЬ ВРОЖДЕННЫХ ПОРОКОВ СЕРДЦА СРЕДИ РУМЫНСКИХ ДЕТЕЙ — ОПЫТ ОДНОГО ЦЕНТРА</article-title><trans-title-group xml:lang="en"><trans-title>THE PREVALENCE OF CONGENITAL HEART DISEASES AMONG ROMANIAN CHILDREN — EXPERIENCE OF A SINGLE CENTER</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Hrusca</surname><given-names>Adrian</given-names></name><name name-style="western" xml:lang="en"><surname>Hrusca</surname><given-names>Adrian</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cluj-Napoca</p></bio><bio xml:lang="en"><p>Cluj-Napoca</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Rachisan</surname><given-names>Andreea Liana</given-names></name><name name-style="western" xml:lang="en"><surname>Rachisan</surname><given-names>Andreea Liana</given-names></name></name-alternatives><bio xml:lang="ru"><p>3–5 Crisan Street, Cluj-Napoca 400371</p></bio><bio xml:lang="en"><p>3–5 Crisan Street, Cluj-Napoca 400371</p></bio><email xlink:type="simple">andreea_rachisan@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Chira</surname><given-names>Emanuel</given-names></name><name name-style="western" xml:lang="en"><surname>Chira</surname><given-names>Emanuel</given-names></name></name-alternatives><bio xml:lang="en"><p>Cluj-Napoca</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Oprita</surname><given-names>Simona</given-names></name><name name-style="western" xml:lang="en"><surname>Oprita</surname><given-names>Simona</given-names></name></name-alternatives><bio xml:lang="en"><p>Cluj-Napoca</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Andreica</surname><given-names>Mariana</given-names></name><name name-style="western" xml:lang="en"><surname>Andreica</surname><given-names>Mariana</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cluj-Napoca</p></bio><bio xml:lang="en"><p>Cluj-Napoca</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cainap</surname><given-names>Simona</given-names></name><name name-style="western" xml:lang="en"><surname>Cainap</surname><given-names>Simona</given-names></name></name-alternatives><bio xml:lang="ru"><p>Cluj-Napoca</p></bio><bio xml:lang="en"><p>Cluj-Napoca</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>University of Medicine &amp; Pharmacy “Iuliu Hatieganu”, Department of Pediatrics II</institution><country>Румыния</country></aff><aff xml:lang="en"><institution>University of Medicine &amp; Pharmacy “Iuliu Hatieganu”, Department of Pediatrics II</institution><country>Romania</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>University of Medicine &amp; Pharmacy “Iuliu Hatieganu”, Hospital of&#13;
Cardiovascular Surgery</institution><country>Румыния</country></aff><aff xml:lang="en"><institution>University of Medicine &amp; Pharmacy “Iuliu Hatieganu”, Hospital of&#13;
Cardiovascular Surgery</institution><country>Romania</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>28</day><month>07</month><year>2014</year></pub-date><volume>0</volume><issue>7-eng</issue><fpage>47</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Hrusca A., Rachisan A., Chira E., Oprita S., Andreica M., Cainap S., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Hrusca A., Rachisan A., Chira E., Oprita S., Andreica M., Cainap S.</copyright-holder><copyright-holder xml:lang="en">Hrusca A., Rachisan A., Chira E., Oprita S., Andreica M., Cainap S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/624">https://russjcardiol.elpub.ru/jour/article/view/624</self-uri><abstract><sec><title>Цель</title><p>Цель. Врожденные пороки сердца (CHD), являющиеся ведущей причиной младенческой смертности, становятся важной проблемой общественного здравоохранения. Тенденцией последнего времени в области диагностики CHD направлены на конкретный фенотип и по причине длительного времени наблюдения редко бывают доступны для большей части детского населения.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Мы представляем распространенность CHD за последние 5 лет среди румынских детей. Лица с CHD были классифицированы по нескольким критериям, в том числе вида патологии, ассоциации патологии с различными синдромами и аномалиями, послеродовыми осложнениями или лечением.</p></sec><sec><title>Результаты</title><p>Результаты. Общее количество CHD при рождении увеличилось. В целом, увеличилось распространенность диагностирование пороков у младенцев и дошкольников. Изолированные септальные пороки, такие как дефект межпредсердной перегородки (ASD) присутствовали у 29,69% пациентов, тогда как транспозиция магистральных сосудов присутствовала у 1,87% детей, соответственно. Среди серьезных дефектов, тетрада Фалло — ассоциация атрезия/гипоплазия легочной артерии проявила наибольшую распространенность. Учитывая симптоматические CHD, наиболее высокий уровень заболеваемости (78,78%) был отмечен для синдрома Дауна, сопровождаемого синдромом Тернера. Из наиболее частых послеродовых осложнений у больных CHD наблюдалась кардиомегалия, затем легочная гипертензия. Только 29,94% пациентов, были подвергнуты хирургическим операциям, остальные оставались на лекарственной терапии. Наивысший уровень заболеваемости был отмечен при тетраде Фалло (42,85%), а также изолированных септальных пороках. В среднем, больные с тетрадой Фалло были прооперированы через 16,6 месяцев после установления диагноза, в то время как с транспозицией магистральных сосудов через 2,5 месяцев.</p></sec><sec><title>Заключение</title><p>Заключение. Сообщение о растущем преобладании CHD было подтверждено в настоящем исследовании. Это произошло, в основном, за счет увеличения количества изолированных септальных дефектов, диагностируемых в младенчестве. В будущем, этиология CHD нуждается в дальнейшем уточнении и создание перспективных реестров дефектов при рождении, охватывающих большие группы населения, необходимо для определения точной распространенности CHD.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. Congenital heart defects (CHD) are the leading cause of infant mortality becoming an important public health problem. Time trends in CHD by specific phenotype and with long follow-up time are rarely available for a large pediatric population.</p></sec><sec><title>Material and methods</title><p>Material and methods. We present the prevalence of CHD over the past 5 years among Romanian children. Individuals with CHDs were classified by several criteria including type of pathology, association of the pathology with various syndromes and abnormalities, postnatal complications or treatment.</p></sec><sec><title>Results</title><p>Results. The overall CHD birth prevalence increased. Generally, prevalence increased for defects diagnosed in infancy and preschoolers patients. Isolated septal defects such as atrial septal defect (ASD) was present in 29,69% of patients while transposition of the great vessels was present in 1,87% of children, respectively. Among the severe defects, tetralogy of Fallot — atresia/hypoplasia of the pulmonary artery association showed the largest prevalence. Considering the syndromatic CHD, the highest incidence (78,78%) was recorded for Down syndrome, followed by Turner syndrome. The most frequent postnatal complication in CHD patients was cardiomegaly, followed by pulmonary hypertension. Only 29,94% of the patients underwent corrective surgery, the rest remained on medication. The highest incidence rate was recorded for tetralogy of Fallot (42,85%), followed by isolated septal defects. On average, tetralogy of Fallot cases were operated on 16,6 months after diagnosis while transposition of the great vessels after 2,5 months.</p></sec><sec><title>Conclusion</title><p>Conclusion. The increasing prevalence of CHDs reported was confirmed in the present study. This is mostly due to an increasing number of isolated septal defects diagnosed in infancy. In the future, the etiology of CHD needs to be further clarified and prospective birth defect registries covering the a large population are needed to determine the exact birth prevalence of CHD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>врожденный порок сердца</kwd><kwd>распространенность</kwd><kwd>дети</kwd><kwd>синдром</kwd><kwd>беременность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>congenital heart disease</kwd><kwd>prevalence</kwd><kwd>children</kwd><kwd>syndrome</kwd><kwd>pregnancy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dolk H, Loane M, Garne E, for the European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123:841–9.</mixed-citation><mixed-citation xml:lang="en">Dolk H, Loane M, Garne E, for the European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123:841–9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010; 375:649–56.</mixed-citation><mixed-citation xml:lang="en">Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010; 375:649–56.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bernier PL, Stefanescu A, Samoukovic G, Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2010; 13:26–34.</mixed-citation><mixed-citation xml:lang="en">Bernier PL, Stefanescu A, Samoukovic G, Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2010; 13:26–34.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Khairy P, Ionescu-Ittu R, Mackie AS, et al. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56:1149–57.</mixed-citation><mixed-citation xml:lang="en">Khairy P, Ionescu-Ittu R, Mackie AS, et al. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56:1149–57.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Williams RG, Pearson GD, Barst RJ, et al. National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006; 47:701–7.</mixed-citation><mixed-citation xml:lang="en">Williams RG, Pearson GD, Barst RJ, et al. National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006; 47:701–7.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Q, Chen H, Correa A, et al. Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002. Birth Defects Res Part A Clin Mol Teratol. 2006; 76:706–13</mixed-citation><mixed-citation xml:lang="en">Yang Q, Chen H, Correa A, et al. Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002. Birth Defects Res Part A Clin Mol Teratol. 2006; 76:706–13</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16:103–13.</mixed-citation><mixed-citation xml:lang="en">Hoffman JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16:103–13.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Bom T, Zomer AC, Zwinderman AH, et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011; 8:50–60.</mixed-citation><mixed-citation xml:lang="en">Van der Bom T, Zomer AC, Zwinderman AH, et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011; 8:50–60.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors andcongenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115:2995–3014.</mixed-citation><mixed-citation xml:lang="en">Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors andcongenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115:2995–3014.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Germanakis I, Sifakis S. The impact of fetal echocardiography on theprevalence of liveborn congenital heart disease. Pediatr Cardiol 2006; 27:465–72.</mixed-citation><mixed-citation xml:lang="en">Germanakis I, Sifakis S. The impact of fetal echocardiography on theprevalence of liveborn congenital heart disease. Pediatr Cardiol 2006; 27:465–72.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby ML. Cardiac development. Oxford: Oxford University Press; 2007.</mixed-citation><mixed-citation xml:lang="en">Kirby ML. Cardiac development. Oxford: Oxford University Press; 2007.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">International Clearinghouse for Birth Defects. Surveillance and research. Available at: http://www.icbdsr.org.</mixed-citation><mixed-citation xml:lang="en">International Clearinghouse for Birth Defects. Surveillance and research. Available at: http://www.icbdsr.org.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hitz MP, Lemieux-Perreault LP, Marshall C, et al. Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet. 2012.</mixed-citation><mixed-citation xml:lang="en">Hitz MP, Lemieux-Perreault LP, Marshall C, et al. Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet. 2012.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
